Cargando…

Development and validation of prognostic nomograms for medullary thyroid cancer

BACKGROUND: This aim of study was to develop and validate clinical nomograms to predict the survival of patients with medullary thyroid cancer. PATIENTS AND METHODS: Patient data were collected from the Surveillance, Epidemiology, and End Results database between 2004 and 2013. All included patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Yong-jun, Fang, Shi-ying, Chen, Lin-lin, Li, Zheng-dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441551/
https://www.ncbi.nlm.nih.gov/pubmed/30988634
http://dx.doi.org/10.2147/OTT.S196205
_version_ 1783407562782146560
author Guan, Yong-jun
Fang, Shi-ying
Chen, Lin-lin
Li, Zheng-dong
author_facet Guan, Yong-jun
Fang, Shi-ying
Chen, Lin-lin
Li, Zheng-dong
author_sort Guan, Yong-jun
collection PubMed
description BACKGROUND: This aim of study was to develop and validate clinical nomograms to predict the survival of patients with medullary thyroid cancer. PATIENTS AND METHODS: Patient data were collected from the Surveillance, Epidemiology, and End Results database between 2004 and 2013. All included patients were randomly assigned into the training and validation sets. Multivariate analysis using Cox proportional hazards regression was performed, and nomograms were constructed. Model performance was evaluated by discrimination and calibration plots. RESULTS: A total of 1,657 patients were retrospectively analyzed. The multivariate Cox model identified age, tumor size, extrathyroidal extension, N stage, and M stage as independent covariates associated with overall survival (OS) and cancer-specific survival (CSS). Nomograms predicting OS and CSS were constructed based on these covariates. The nomograms predicting both OS and CSS exhibited superior discrimination power to that of TNM staging system in the training and validation sets. Calibration plots indicated that both the nomograms in OS and CSS exhibited high correlation to actual observed results. CONCLUSION: The nomograms established in this study provided an alternative tool for prognostic prediction, which may thereby improve individualized assessment of survival risks and lead to the creation of additional clinical therapies.
format Online
Article
Text
id pubmed-6441551
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64415512019-04-15 Development and validation of prognostic nomograms for medullary thyroid cancer Guan, Yong-jun Fang, Shi-ying Chen, Lin-lin Li, Zheng-dong Onco Targets Ther Original Research BACKGROUND: This aim of study was to develop and validate clinical nomograms to predict the survival of patients with medullary thyroid cancer. PATIENTS AND METHODS: Patient data were collected from the Surveillance, Epidemiology, and End Results database between 2004 and 2013. All included patients were randomly assigned into the training and validation sets. Multivariate analysis using Cox proportional hazards regression was performed, and nomograms were constructed. Model performance was evaluated by discrimination and calibration plots. RESULTS: A total of 1,657 patients were retrospectively analyzed. The multivariate Cox model identified age, tumor size, extrathyroidal extension, N stage, and M stage as independent covariates associated with overall survival (OS) and cancer-specific survival (CSS). Nomograms predicting OS and CSS were constructed based on these covariates. The nomograms predicting both OS and CSS exhibited superior discrimination power to that of TNM staging system in the training and validation sets. Calibration plots indicated that both the nomograms in OS and CSS exhibited high correlation to actual observed results. CONCLUSION: The nomograms established in this study provided an alternative tool for prognostic prediction, which may thereby improve individualized assessment of survival risks and lead to the creation of additional clinical therapies. Dove Medical Press 2019-03-27 /pmc/articles/PMC6441551/ /pubmed/30988634 http://dx.doi.org/10.2147/OTT.S196205 Text en © 2019 Guan et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Guan, Yong-jun
Fang, Shi-ying
Chen, Lin-lin
Li, Zheng-dong
Development and validation of prognostic nomograms for medullary thyroid cancer
title Development and validation of prognostic nomograms for medullary thyroid cancer
title_full Development and validation of prognostic nomograms for medullary thyroid cancer
title_fullStr Development and validation of prognostic nomograms for medullary thyroid cancer
title_full_unstemmed Development and validation of prognostic nomograms for medullary thyroid cancer
title_short Development and validation of prognostic nomograms for medullary thyroid cancer
title_sort development and validation of prognostic nomograms for medullary thyroid cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441551/
https://www.ncbi.nlm.nih.gov/pubmed/30988634
http://dx.doi.org/10.2147/OTT.S196205
work_keys_str_mv AT guanyongjun developmentandvalidationofprognosticnomogramsformedullarythyroidcancer
AT fangshiying developmentandvalidationofprognosticnomogramsformedullarythyroidcancer
AT chenlinlin developmentandvalidationofprognosticnomogramsformedullarythyroidcancer
AT lizhengdong developmentandvalidationofprognosticnomogramsformedullarythyroidcancer